Abstract
Background: Diabetes mellitus (DM) caused 1.3 million deaths in 2010, and cardiovascular disease is the leading cause of mortality of diabetic patients. Cardiovascular disease in DM involves complex pathophysiology processes, which are promoted by many risk factors.
Objective: Genetic, epigenetic, lifestyle and environmental factors are responsible for the current epidemic of diabetes and the subsequent increased risk of cardiovascular disease. Over the past years, targets focusing on the increased risk of cardiovascular events in diabetic patients have attracted significant interest.
Conclusion: Within this review, the roles of insulin resistance, endothelial dysfunction and lifestyle changes in the development of cardiovascular disease in diabetic patients are discussed. Potential strategies and challenges in targeting cardiovascular risks in diabetic individuals are also considered.
Keywords: Diabetes mellitus (DM), cardiovascular disease, insulin resistance, endothelium, cardiovascular risk, hyperglycaemia.
Current Drug Targets
Title:Roles of Insulin Resistance, Endothelial Dysfunction and Lifestyle Changes in the Development of Cardiovascular Disease in Diabetic Patients
Volume: 18 Issue: 15
Author(s): Dongdong Sun, Wanrong Man and Lei Zhang*
Affiliation:
- 127 West Changle Road, Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi 710032,China
Keywords: Diabetes mellitus (DM), cardiovascular disease, insulin resistance, endothelium, cardiovascular risk, hyperglycaemia.
Abstract: Background: Diabetes mellitus (DM) caused 1.3 million deaths in 2010, and cardiovascular disease is the leading cause of mortality of diabetic patients. Cardiovascular disease in DM involves complex pathophysiology processes, which are promoted by many risk factors.
Objective: Genetic, epigenetic, lifestyle and environmental factors are responsible for the current epidemic of diabetes and the subsequent increased risk of cardiovascular disease. Over the past years, targets focusing on the increased risk of cardiovascular events in diabetic patients have attracted significant interest.
Conclusion: Within this review, the roles of insulin resistance, endothelial dysfunction and lifestyle changes in the development of cardiovascular disease in diabetic patients are discussed. Potential strategies and challenges in targeting cardiovascular risks in diabetic individuals are also considered.
Export Options
About this article
Cite this article as:
Sun Dongdong, Man Wanrong and Zhang Lei*, Roles of Insulin Resistance, Endothelial Dysfunction and Lifestyle Changes in the Development of Cardiovascular Disease in Diabetic Patients, Current Drug Targets 2017; 18 (15) . https://dx.doi.org/10.2174/1389450117666160715145518
DOI https://dx.doi.org/10.2174/1389450117666160715145518 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inflammatory Risk Factors and Pathologies Associated with Alzheimers Disease
Current Alzheimer Research Role of Endothelin in Diabetic Retinopathy
Current Vascular Pharmacology Application of Carbon Monoxide for Transplantation
Current Pharmaceutical Biotechnology How to Advise Aspirin Use in Patients Who Need NSAIDs
Current Pharmaceutical Design New Strategies for Managing Anemia of Chronic Kidney Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Cognitive and Functional Influences of Vildagliptin, a DPP-4 Inhibitor, Added to Ongoing Metformin Therapy in Elderly with Type 2 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets Hypertension and Heart Failure with Preserved Ejection Fraction: Connecting the Dots
Current Vascular Pharmacology QSAR Studies of PTP1B Inhibitors: 1, 2-Naphthoquinone Derivatives
Letters in Drug Design & Discovery SGLT2 Inhibitors in Diabetes Mellitus Treatment
Reviews on Recent Clinical Trials The Use of Infliximab in Dermatology
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Medicinal Chemistry Approaches to the Inhibition of Dipeptidyl Peptidase IV
Current Topics in Medicinal Chemistry Clinical Significance of the Cardio-Ankle Vascular Index (CAVI) in Hypertension
Current Hypertension Reviews Evaluation of Thiol/Disulfide Homeostasis in Pediatric Patients with Diabetic Ketoacidosis
Combinatorial Chemistry & High Throughput Screening Therapeutic Implications of Gene Deletion of Ligands and Receptors of Members of TNF Superfamily
Medicinal Chemistry Reviews - Online (Discontinued) Semicarbazide-Sensitive Amine Oxidase/Vascular Adhesion Protein 1: Recent Developments Concerning Substrates and Inhibitors of a Promising Therapeutic Target
Current Medicinal Chemistry Potential Therapeutic Targeting of Platelet-Mediated Cellular Interactions in Atherosclerosis and Inflammation
Current Medicinal Chemistry Action Mechanisms of Chinese Herbal Compound at the Molecular Level
Letters in Drug Design & Discovery Ivabradine: The Hope for a Good Treatment of Ischemic Heart Disease
Current Medicinal Chemistry Peroxisome Proliferator-Activated Receptor (PPAR)β /δ: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome
Current Molecular Pharmacology Adipose Tissue in the Regulation of Inflammation
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)